IP Library Granted Patent US 9,340,508
Granted Patent B2
US 9,340,508 · App. 14/661,105 · Granted May 17, 2016

Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof

Inventors: Silvano Spinelli (Milan, IT); Valeria Livi (Milan, IT)
Assignee: CLOVIS ONCOLOGY ITALY S.R.L.
C07D215/22C07C217/44C07C269/04C07C271/24C07C2101/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,340,508
App. No.
14/661,105
Granted
May 17, 2016
Kind
B2
Abstract

A process for the preparation in high yields and purity of the compound 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.

Claims (6)

1. A compound of formula (XI) or (XIa):

wherein R′ is hydrogen and R is selected from benzyl, acetyl, benzoyl, trifluoromethanesulfonyl, benzenesulfonyl, p-toluenesulfonyl, methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, allyloxycarbonyl and benzyloxycarbonyl optionally substituted on the aromatic ring with up to three substituents selected from halogen, cyano and trifluoromethyl; or R′ is trimethylsilyl and R is tert-butoxycarbonyl; or R and R′ taken together with the nitrogen atom they are linked to form a phthalimido group.

2. A compound of formula (XII):

wherein X is selected from the group consisting of Cl, Br and I; wherein R′ is hydrogen and R is selected from benzyl, acetyl, benzoyl, trifluoromethanesulfonyl, benzenesulfonyl, p-toluenesulfonyl, methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, allyloxycarbonyl and benzyloxycarbonyl optionally substituted on the aromatic ring with up to three substituents selected from halogen, cyano and trifluoromethyl; or R′ is trimethylsilyl and R is tert-butoxycarbonyl; or R and R′ taken together with the nitrogen atom they are linked to form a phthalimido group.

3. A compound as claimed in claim 1 , wherein the compound is 1-[(4-Hydroxy-6-methoxyquinolin-7-yloxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane.

4. A compound as claimed in claim 2 , wherein the compound is 1-[(4-Chloro-6-methoxyquinolin-7-yloxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2015
From: SPINELLI, SILVANO; LIVI, VALERIA
To: EOS ETHICAL ONCOLOGY SCIENCE, S.P.A., ABBREVIATED FORM EOS S.P.A.
Reel/Frame 035190/0460 →
CHANGE OF NAME Recorded Mar 18, 2015
From: EOS ETHICAL ONCOLOGY SCIENCES S.P.A. ABBREVIATED FORM EOS S.P.A.
To: CLOVIS ONCOLOGY ITALY S.R.L.
Reel/Frame 035190/0487 →
Priority Claims (1)
IT MI2009A0397 · Mar 16, 2009 · national
Continuity (3)
Division 14138302 · Dec 23, 2013
Division 13256722
Related Publication 20150191429A1 · Jul 9, 2015